Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
Porta, S; Egger, G; Sadjak, A; Supanz, S; Rangetiner, B; Pürstner, P.
Adrenaline application by controlled release system shows that it does play a physiological role in glycogenolysis.
EXP PATHOL. 1984; 25(3): 169-176.
Doi: 10.1016/S0232-1513(84)80036-5
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Führende Autor*innen der Med Uni Graz
- Porta Sepp
- Co-Autor*innen der Med Uni Graz
- Pürstner Peter
- Sadjak Anton
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- In a frequently cited paper Sokal , Sarcione and Henderson (1964) doubted the physiological glycogenolytic role of adrenaline (A). By using isolated perfused rat livers, they found adrenaline to be effective at doses higher than 140 ng/ml while a mere tenfold increase in glucagon leads to expressed glycogenolysis. Our in vivo experiments carried out with controlled release systems for adrenaline show that marked glycogenolysis takes place at an adrenaline serum level of not more than 20 ng/ml while endogenous glucagon levels do not differ from controls. We think, that the reason for those controversial results lies in the fact that Sokal , Sarcione and Henderson (1964) diminished the glycogenolytic action of adrenaline by blocking its alpha-component for the reason of an easier perfusion, and they further diminished its glycogenolytic action by omitting corticosterone, which is well known for its permissive role in adrenaline induced glycogenolysis in vivo.
- Find related publications in this database (using NLM MeSH Indexing)
- Animals -
- Blood Glucose - metabolism
- Comparative Study - metabolism
- Delayed-Action Preparations - metabolism
- Dopamine - blood
- Epinephrine - administration and dosage
- Glucagon - blood
- Liver - metabolism
- Liver Glycogen - metabolism
- Norepinephrine - blood
- Rats - blood
- Rats, Inbred Strains - blood